- Tytuł:
- Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study
- Autorzy:
- Źródło:
- In The Breast October 2017 35:115-121
Czasopismo naukowe